Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Physiol Res ; 60(4): 647-58, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21574763

RESUMO

The aims of our study were to evaluate plasma levels of gut hormones in children with Type 1 diabetes mellitus (T1DM) in comparison with healthy controls and to correlate plasma concentrations of gut hormones with blood biochemistry, markers of metabolic control and with anthropometric parameters. We measured postprandial levels of specific gut peptide hormones in T1DM children. Amylin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), ghrelin, leptin, pancreatic polypeptide (PP), and polypeptide YY (PYY) were assessed in 19 T1DM children and 21 healthy reference controls. Multiplex assay kit (LINCOplex(®)) was used for determination of the defined plasma hormone levels. T1DM subjects had significantly reduced amylin (p<0.001) and ghrelin (p<0.05) levels, whereas GIP (p<0.05) was elevated when compared with healthy controls. Plasma levels of other measured hormones did not differ statistically between the studied groups. Further analysis of T1DM patients demonstrated an association between body mass index and GLP-1 (r=0.4642; p<0.05), leptin (r=0.5151; p<0.05), and amylin (r=0.5193; p<0.05). Ghrelin levels positively correlated with serum HDL cholesterol (r=0.4760; p<0.05). An inverse correlation was demonstrated with triglycerides (TG) (r= -0.5674; p<0.01), insulin dosage (r= -0.5366; p<0.05), and HbA1c% (r= -0.6864; p<0.01). Leptin was inversely correlated with TG (r= -0.6351; p<0.01). Stepwise regression analysis was performed to enlighten the predictive variables. Our study demonstrated an altered secretion pattern of gut peptide hormones in T1DM children. A close correlation was revealed between these peptides as well as with blood biochemistry, markers of metabolic control and with anthropometric parameters. Further studies are essential to explore this issue in T1DM children.


Assuntos
Diabetes Mellitus Tipo 1/sangue , Hormônios Gastrointestinais/sangue , Hormônios Peptídicos/sangue , Adolescente , Fatores Etários , Biomarcadores/sangue , Criança , Diabetes Mellitus Tipo 1/diagnóstico , Feminino , Humanos , Masculino , Valor Preditivo dos Testes
2.
Physiol Res ; 58(2): 179-184, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-18380539

RESUMO

A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (ADMA), is known to act as an endogenous inhibitor of endothelial nitric oxide synthase. The aim of this study was to establish 1) the relationship between ADMA and ultrasonographically or biochemically determined endothelial dysfunction in children, and 2) the effect of folate supplementation on these parameters. The study cohort included 32 children with familial hypercholesterolemia (FH), 30 with diabetes mellitus type 1 (DM1) and 30 age-matched healthy children as the control group. Furthermore, twenty-eight randomly selected FH and DM1 children were re-examined after 3-months supplementation with folic acid. Baseline levels of ADMA and oxidized low density lipoproteins (oxLDL) were significantly higher in FH group than in DM1 and healthy children. Children in DM1 group had significantly lower concentration of homocysteine, but ADMA levels were normal. Folic acid supplementation significantly lowered homocysteine and hsCRP levels in both FH and DM1 group; however, ADMA and oxLDL concentrations remained unaltered. In conclusion, ADMA and oxLDL appear to be associated with endothelial dysfunction in children with FH. Administration of folic acid did not influence these markers in both FH and DM1 children.


Assuntos
Arginina/análogos & derivados , Diabetes Mellitus Tipo 1/metabolismo , Ácido Fólico/administração & dosagem , Hiperlipoproteinemia Tipo II/tratamento farmacológico , Hiperlipoproteinemia Tipo II/metabolismo , Complexo Vitamínico B/administração & dosagem , Adolescente , Anticolesterolemiantes/administração & dosagem , Arginina/sangue , Azetidinas/administração & dosagem , Biomarcadores/sangue , Criança , Quimioterapia Combinada , Endotélio Vascular/diagnóstico por imagem , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Ezetimiba , Feminino , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Hiperlipoproteinemia Tipo II/epidemiologia , Lipoproteínas LDL/sangue , Masculino , Fatores de Risco , Ultrassonografia
3.
Physiol Res ; 56(2): 203-212, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-16555941

RESUMO

The aim of this study was to assess the influence of regular daily consumption of white wine on oxidative stress and cardiovascular risk markers. Forty-two healthy male volunteers consumed 375 ml of white wine daily. Each participant provided three venous blood samples (before wine consumption, following the wine consumption period and again a month later). Levels of superoxide dismutase, glutathione peroxidase, reduced glutathione, total antioxidant capacity, total cholesterol, HDL-cholesterol, apolipoprotein A I, apolipoprotein B, triglycerides, paraoxonase 1, C-reactive protein, homocysteine, thiobarbituric acid reactive substances (TBARS) and advanced oxidation protein products (AOPP) were measured. Immediately following the month of white wine consumption there was a significant increase in HDL-cholesterol (p<0.0001), paraoxonase 1 (p<0.001), glutathione peroxidase (p<0.001) and reduced glutathione (p<0.01) levels, a decrease in superoxide dismutase activities (p<0.0001), and a decrease in oxidation protein products (p<0.001) and TBARS (p<0.05) concentrations. However, there was also a clear increase in homocysteine (p<0.0001) after a month of white wine consumption. The results of our non-placebo controlled trial suggest that regular daily white wine consumption is associated not only with both antioxidative and antiatherogenic effects but also with a potentially proatherogenic increase of homocysteine concentrations.


Assuntos
Consumo de Bebidas Alcoólicas/metabolismo , Biomarcadores/sangue , Doenças Cardiovasculares/etiologia , Homocisteína/sangue , Estresse Oxidativo , Vinho , Adulto , Consumo de Bebidas Alcoólicas/sangue , Apolipoproteínas/sangue , Arildialquilfosfatase/sangue , Proteína C-Reativa/metabolismo , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/metabolismo , Colesterol/sangue , Estudos de Coortes , República Tcheca , Glutationa/sangue , Glutationa Peroxidase/sangue , Humanos , Fígado/enzimologia , Masculino , Fatores de Risco , Superóxido Dismutase/sangue , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Triglicerídeos/sangue
4.
Epidemiol Mikrobiol Imunol ; 55(1): 3-16, 2006 Feb.
Artigo em Tcheco | MEDLINE | ID: mdl-16528894

RESUMO

H. pylori infection is common worldwide, and is acquired primarily during childhood. The mechanism of acquisition is not clear. In recent years the main focus of interest has been on the transmission of infection from family members to children. The main risk factor for acquiring the infection seems to be low socioeconomic status. H. pylori is associated with gastritis, duodenal ulcers, MALT lymphoma, and gastric adenocarcinoma. Extra-intestinal clinical manifestations have also been reported. However, the infection is often asymptomatic in children and the role of H. pylori infection in gastric manifestations is the subject of conflicting reports. Methods for the diagnosis of H. pylori infection in children are subdivided into invasive and noninvasive. There is a lack of consensus on treatment. The treatment of H. pylori is hampered by high macrolide-resistance. Treatment with proton pump-based triple therapy for 1-2 weeks gives the best eradication rates when combined with supplements containing probiotics. Multinational, multicentre studies in childhood are essential to extend current knowledge to avoid long-term gastroduodenal disease sequelae.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , Criança , Gastroenteropatias/diagnóstico , Gastroenteropatias/tratamento farmacológico , Gastroenteropatias/microbiologia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/transmissão , Humanos
5.
Physiol Res ; 54(1): 87-95, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15717846

RESUMO

The aim of this study was to observe the effect of folate and antioxidants alone on homocysteine levels and oxidative stress markers, and to evaluate whether their co-administration promotes their effects. One hundred patients with hyperhomocysteinemia were randomized into four equal groups, which were then treated with folate, antioxidants or folate plus antioxidants for 2 months; group IV was a control group. Serum homocysteine, folate and oxidative stress markers were measured before the study, at the end of folate and/or antioxidants administration and 3 months later. Folate caused a significant decrease in homocysteine concentration. Antioxidants did not influence homocysteine concentration, but they improved the antioxidative defense (plasma antioxidant capacity and intraerythrocyte glutathione were increased) and partially prevented lipid peroxidation (malondialdehyde level was slightly decreased). Supplementation with folate had a similar effect on intracellular glutathione and plasma malondialdehyde. Simultaneous administration of folate and antioxidants did not show any additive effect with the exception of a slower decrease of folate concentration after its supplementation had been discontinued. Folate may be considered as an effective antioxidant in patients with hyperhomocysteinemia; this can be a result of decreased production of free radicals due to a reduced level of homocysteine. Its antioxidative effect cannot be promoted by co-administration of antioxidants.


Assuntos
Antioxidantes/administração & dosagem , Ácido Fólico/administração & dosagem , Hiper-Homocisteinemia/tratamento farmacológico , Hiperlipidemias/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Adulto , Idoso , Biomarcadores , Quimioterapia Combinada , Feminino , Homocisteína/sangue , Humanos , Hiper-Homocisteinemia/metabolismo , Hiperlipidemias/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade
6.
Physiol Res ; 54(4): 429-36, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15588143

RESUMO

Oxidative stress is probably a pathophysiological process leading to disadvantageous outcomes in diabetic pregnancies. We aimed to map a complex of potential markers of oxidative stress in this condition. Diabetic mothers had significantly higher concentrations of thiobarbituric acid reactive substances in the plasma [TBARS] both before (p<0.0001) and after (p<0.001) delivery and also their newborns showed higher values of TBARS (p<0.0001) in comparison with the control group. Diabetic mothers also showed lower concentrations of reduced glutathione in erythrocytes [GSH] both before (p<0.05) and after (p<0.01) delivery and their infants also had lower levels of GSH (p<0.0001). We found a lower total antioxidative capacity of plasma [AOC] before delivery (p<0.05) in the diabetic group in comparison with the control group. Newborns of diabetic mothers had higher plasmatic concentrations of apolipoproteine B [apo B] (p<0.05), higher erythrocyte glutathione peroxidase [GPx] activity (p<0.05) and lower pH (p<0.001) in the umbilical cord blood, when compared with infants of control non-diabetic mothers. We conclude that pregestational and gestational diabetes mellitus represent increased oxidative stress for both mother and her infant. TBARS in plasma are a valuable marker of oxidative stress in this condition. Disruption of glutathione peroxidase/glutathione pattern can be involved in pathophysiology of enhanced oxidative stress in diabetic pregnancies.


Assuntos
Parto Obstétrico , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Gestacional/metabolismo , Estresse Oxidativo/fisiologia , Adulto , Índice de Apgar , Biomarcadores , Doenças Cardiovasculares/fisiopatologia , Cesárea , Diabetes Mellitus Tipo 1/enzimologia , Diabetes Gestacional/enzimologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Recém-Nascido , Metabolismo dos Lipídeos , Lipoproteínas/sangue , Masculino , Gravidez , Fatores de Risco , Caracteres Sexuais , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
7.
Acta Paediatr ; 93(5): 707-9, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15174799

RESUMO

AIM: To evaluate the occurrence and clinical characteristics of Helicobacter heilmannii infection among children presenting with dyspeptic symptoms. METHOD: Prospective cohort study of 580 patients. RESULTS: Of all examined dyspeptic children, 26.4% were infected with spiral-shaped organisms, and 0.9% of patients were found to be infected with spiral H. heilmannii-like organisms. CONCLUSION: In children with dyspeptic symptoms, the possible presence of gastroduodenal disease due to H. heilmannii should be considered. Further studies are needed to clarify H. heilmannii-related gastroduodenal pathology in the paediatric population.


Assuntos
Gastroenteropatias/diagnóstico , Infecções por Helicobacter/diagnóstico , Helicobacter heilmannii/isolamento & purificação , Adolescente , Antibacterianos/uso terapêutico , Estudos de Coortes , República Tcheca/epidemiologia , Feminino , Gastroenteropatias/tratamento farmacológico , Gastroenteropatias/epidemiologia , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/epidemiologia , Helicobacter heilmannii/efeitos dos fármacos , Helicobacter pylori/efeitos dos fármacos , Helicobacter pylori/isolamento & purificação , Humanos , Masculino , Prevalência , Estudos Prospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...